- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Deadline looms for new proposals
The deadline for proposals for the new EU R&D framework program for 2007 to 2013 (FP7) is 8 May 2007.
The deadline for proposals for the new EU R&D framework program for 2007 to 2013 (FP7) is 8 May 2007. ICT for Health (eHealth) is heavily involved in this new call for proposals, with the following priorities: personal health systems for monitoring and point-of-care diagnostics, risk assessment and patient safety, and virtual physiological human. You will find more information on FP7 on the following website: cordis.europa.eu/fp7/home_en.html. More specific information about information society technologies is available on cordis.europa.eu/fp7/ict/.
The EU R&D program is open for international collaboration. There are restrictions, however, on the possibilities to get EU funding for groups from industrialized countries such as Japan.
For more details, see the following websites:
cordis.europa.eu/ist/international/home.htmlwww.euroasia-it.org.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
